Data from COINOTAG DATA
Strong bullish bias
4 bullish · 3 neutral · 0 bearish · 7 indicator groups
Novo Nordisk is a Danish pharmaceutical company founded in 1923, operating in more than 185 countries with over a century of history. It trades on the NYSE as an American Depositary Receipt (ADR) under the ticker NVO. The company has grown to account for a significant portion of Denmark's GDP and has at times been Denmark's most valuable company. The company's defining catalyst is semaglutide, a GLP-1 receptor agonist. Ozempic is approved for diabetes and Wegovy — at a higher dose — is approved for obesity.
With leveraged products the whole margin can be lost quickly; this page is not investment advice.
Session open, intraday change +1.09%
FAQ
The latest price on this page (2026-11-09 19:45 UTC) is $41.62. It is a 24/7 price: it also moves outside the session and can differ from the NVO closing price on the stock exchange.
Market cap is the share price multiplied by the total number of shares outstanding. With the share count unchanged, Novo Nordisk's market cap moves by the same percentage as the NVO share price.
NVO is the trading code (ticker) of Novo Nordisk stock on the US exchange.
The US exchange regular session runs 09:30–16:00 (New York time); public holidays are not taken into account. The 24/7 price on this page keeps moving while the session is closed.
The stock exchange is closed at the weekend; meanwhile buyers and sellers on the 24/7 market set the price on this page. NVO can open at a different price on Monday.
They are close but not the same number. The NVO exchange price forms only in the regular session; the 24/7 price also forms outside it and carries no ownership, voting or dividend rights.
The funding rate is 0.0000%; the next payment is at 2026-11-10 00:00 UTC. When it is positive, longs pay shorts; when it is negative, shorts pay longs.
Volume can be thin outside the session and the price can move sharply; it can gap when the exchange opens. With leveraged products the whole margin can be lost quickly. This page is not investment advice.
This page is not investment advice.